# Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT)

> **NCT03941405** · PHASE2 · COMPLETED · sponsor: **Fundacion Clinic per a la Recerca Biomédica** · enrollment: 52 (actual)

## Conditions studied

- Hyponatremia With Excess Extracellular Fluid Volume
- Cirrhosis, Liver

## Interventions

- **DRUG:** Albumin treatment

## Key facts

- **NCT ID:** NCT03941405
- **Lead sponsor:** Fundacion Clinic per a la Recerca Biomédica
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-01
- **Primary completion:** 2024-12-28
- **Final completion:** 2025-01-30
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03941405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03941405, "Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03941405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*